EUVIMEDEUVIMED entdecken
Open Access

Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum

Mason J Handford iD, Yuexin Li, Teresa Riscoe, Katherine M Liebman, Xiaowei Zhang, Jane X Kelly iD, Michael K Riscoe iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Mason J Handford und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Physiology and Biochemistry Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United St…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Drug Resistance, Multiple, Aminoquinolines. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A structure activity relationship study was conducted to optimize metabolic stability and in vivo activity of amodiaquine analog antimalarials. Antiplasmodial activity of synthesized amodiachins (ADCs) were evaluated against drug-sensitive and drug-resistant strains of Plasmodium falciparum. Select compounds were tested in Plasmodium yoelli murine models. Structural modifications, including introduction of a piperidine ring and varied N-alkyl substitutions enhanced antiparasitic activity, metabolic stability, and in vivo efficacy. Compound 43 (ADC-028) emerged as a standout candidate, exhibiting nanomolar activity against drug-sensitive and multidrug-resistant P. falciparum, minimal cytotoxicity, and favorable murine microsomal stability (t1/2 = 48.2 min). In vivo, 43 achieved a nonrecrudescence dose at 16 mg/kg/d and a single dose cure at 50 mg/kg. Pharmacokinetic analysis of 43 showed excellent metabolic stability (T1/2 = 84 h) and oral bioavailability (F = 76%). This study identifies 43 as a potential candidate for further evaluation as a novel compound to overcome drug-resistant malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium falciparumDrug Resistance, MultipleAminoquinolinesAnimalsMiceStructure-Activity RelationshipMicrosomes, LiverHumansParasitic Sensitivity TestsDrug Discovery

Substanzen

AntimalarialsAminoquinolines4-aminoquinoline

Autor:innen und Institutionen

  • Chemical Physiology and Biochemistry Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United States.
  • Portland VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, United States.
  • Department of Chemistry, Portland State University, 1825 SW Broadway, Portland, Oregon 97201, United States.
  • Molecular Microbiology and Immunology Department, Oregon Health & Science University, 3181 SW Sam Jackson Boulevard, Portland, Oregon 97239, United States.

ORCID-Profile: Mason J Handford, Jane X Kelly, Michael K Riscoe

Förderung

  • BLRD VA
  • NIAID NIH HHS
  • U.S. Department of Veterans Affairs
  • National Institute of Allergy and Infectious Diseases
  • U.S. Department of Defense
  • Open Philanthropy Project

Zitieren

APA

Handford, M. J., Li, Y., Riscoe, T., Liebman, K. M., Zhang, X., Kelly, J. X., & Riscoe, M. K. (2025). Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00936

Vancouver

Handford MJ, Li Y, Riscoe T, Liebman KM, Zhang X, Kelly JX, et al. Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00936

BibTeX
@article{Handford2025,
  author = {Handford, Mason J and Li, Yuexin and Riscoe, Teresa and Liebman, Katherine M and Zhang, Xiaowei and Kelly, Jane X and Riscoe, Michael K},
  title = {Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant Plasmodium falciparum},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00936}
}
Kostenlos starten →